Silence Therapeutics plc

Company Information

Address:

The Royal Institute of Great Britain
21 Albermarle Street
London
W1S 4BS

Tel:

+44 (0) 20 7491 6520

Fax:

+44 (0) 20 7491 6521

E-Mail:

Secretary:

Melvyn Davies

Registrar:

Company Overview

Silence Therapeutics is the leading RNAi therapeutics company in Europe. The Company has developed novel, proprietary short interfering RNA (“siRNA”) molecules. These molecules provide a number of advantages over conventional siRNA molecules as they show increased stability against nuclease degradation. In addition, the Company has developed a proprietary systemic delivery system, AtuPLEX. This enables the delivery of siRNA molecules to targeted diseased tissues and cells in the body, whilst increasing their bioavailability and circulation times.

Annual Reports

Description Report Date Published

Interim Reports

Description Report Date Published
Interim Report 201130-06-201121-09-2011
Interim Report 201030-06-201020-09-2010
Interim Report 200930-06-200901-01-1970
Interim Report 200930-06-200901-01-1970
Interim Report 200830-06-200824-09-2008
Interim Report 200730-06-200727-09-2007

Dividend Histroy

Type Dividend Payment Date
A B C D E F G
H I J K L M
N O P Q R S T
U V W X Y Z #